Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. - Test2 - elhamkhani - TriplyDB

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q34973576

about

A Systematic Review of Spiritually Based Interventions and Psychoneuroimmunological Outcomes in Breast Cancer Survivorship Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy Richter transformation of CLL.Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients.Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.The impact of mindfulness-based interventions on symptom burden, positive psychological outcomes, and biomarkers in cancer patients The Association between Telomere Length and Cancer Prognosis: Evidence from a Meta-Analysis.Molecular pathogenesis of chronic lymphocytic leukemia.Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia How we treat Richter syndrome.A systematic review on Richter syndrome: what is the published evidence?Predictive markers and driving factors behind Richter syndrome development.Telomere dysfunction and its role in haematological cancer.Risk factors for Richter syndrome in chronic lymphocytic leukemia.The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications.Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia.Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia Richter Syndrome in Chronic Lymphocytic Leukemia.The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity.Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.Immunophenotype predicts survival time in dogs with chronic lymphocytic leukemia.Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.Mindfulness-based cancer recovery and supportive-expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors.Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.Shortened telomeres: a driving force behind leukemia?Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

P2860

Q28072197-6F3B8F56-26FB-4F52-9A25-F2621B3B1504 Q28077136-AA5AF41E-3878-4507-B041-CB35CD87A634 Q30249283-AC706530-9FDF-4435-A616-3E05806EAE4C Q30986040-4C557727-D269-46B3-B4B4-D8F70D4D596C Q33903379-D0940AA3-92E5-4417-8E26-A116EBB6C58B Q35094617-ED1AF4B4-498D-4CEA-9FC6-4F1D9808699B Q35140580-7521004D-6C46-4A95-BC32-05C06F9B9A57 Q35643026-CA209E19-F504-4293-8FD1-D97C4B701178 Q35687661-863C3F77-0E66-4A7B-8D61-EE5A91649714 Q35692421-764AC783-D90C-4D65-B868-35E0F9EEBB1E Q36290321-374C54E0-A1BE-42F6-B305-A3BE0B5CA525 Q37040876-583DCA1F-38B9-4296-BCDD-1E7BADB7368B Q37225819-E14A232C-7BEA-4BF0-8E50-7EFBB206365F Q37636962-E7C895C9-F6C1-4385-A3F1-96178716CD2D Q37676244-D7727FD5-57B1-4802-BB8D-056D6D143BE3 Q37854712-CDED8023-0A11-4B87-B585-63EB0A3348E0 Q37974664-8A728BB8-A90D-48B7-A1CE-A46EEA8C10CA Q38248873-F8EF4F22-B8B3-403D-98BC-5F19ACADDBC2 Q38286344-A55CC2B4-7BC3-41E8-B0D7-A316562B1FC1 Q38612097-4F8AD763-03B0-461B-9157-E33B9AF86967 Q38835730-A57E2CB1-F786-40C9-879E-23127927E0AA Q38896306-1DAFA1DA-EBD3-4E8B-8F36-473CED7C2EDC Q39227773-D8367638-6531-4B11-B967-59C46EBD5851 Q40037434-85FCC82E-2EC8-43F4-80D5-165F55A19675 Q40929264-9836E5DA-D155-4D9A-B2C6-769F53898CED Q42250056-04EB375B-6615-43BD-A9EF-772302E3B899 Q43982704-DACDA635-4AEF-44D9-9B50-0983CD3FFDE1 Q44078664-DA9E7E8D-D06A-4986-9CC8-B6F076D6740E Q48060870-4FD28588-56FD-4C49-8E4B-A50FDCC65167 Q48335780-C88094E0-8057-4AC2-A19D-37F065D4ADFF Q50074012-0116EE98-1280-47EC-A3E1-515DA51754F7 Q51039630-6906A9FD-713D-4324-A572-7D4099A48417 Q51548976-8501858D-DE90-49B5-9DE7-19032DAA4011 Q51773652-0987BAB9-9A69-47B0-8518-38B087A6D58D Q52941092-F4FF228E-564E-4B0F-87B4-46DC63267BC5 Q58000942-6FD0A11A-FE7F-4E54-9DA4-E7D7278895F6

P2860

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q34973576

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Telomere length is an independ ...... chronic lymphocytic leukemia.

@ast

Telomere length is an independ ...... chronic lymphocytic leukemia.

@en

Telomere length is an independ ...... chronic lymphocytic leukemia.

@nl

type

label

Telomere length is an independ ...... chronic lymphocytic leukemia.

@ast

Telomere length is an independ ...... chronic lymphocytic leukemia.

@en

Telomere length is an independ ...... chronic lymphocytic leukemia.

@nl

prefLabel

Telomere length is an independ ...... chronic lymphocytic leukemia.

@ast

Telomere length is an independ ...... chronic lymphocytic leukemia.

@en

Telomere length is an independ ...... chronic lymphocytic leukemia.

@nl

P1433

Q34973576-4B4697E9-0F81-45B6-B782-6B2A29AB10B5

P1476

Q34973576-34CED646-F53A-4091-895C-99FFC4511CF0

P2093

Q34973576-05A15A4E-4411-4089-99A5-0994C13B8EC6

Q34973576-0BDBFB92-0ABF-4275-B6A4-91AF4CAFEB1D

Q34973576-1DF5A247-B94A-4D4E-9791-6800CB48065C

Q34973576-2F8CA21B-5606-4DE0-95B8-E8B847C77187

Q34973576-505D6274-A91E-437A-8902-C9EBD19CA19E

Q34973576-5103464A-FD4A-48CD-A46B-56EED14F2BF6

Q34973576-5AE55F70-32FD-4C72-8E71-7DE9C97B4F56

Q34973576-91870F49-42B2-4C29-842C-0584CBF46E61

Q34973576-A0707CB1-C380-48DF-AC64-2A7D023C9E16

Q34973576-A1DE7D82-96D6-4D1A-8FB2-CCDA77E3851A

P2860

Q34973576-5112B118-0BA9-4AFB-9693-C8649EB404BD

P2888

Q34973576-586E2D93-5031-403D-91C3-60079E096BEE

P304

Q34973576-A1AF4490-885A-474F-8DF3-3BA0D191F2D8

P31

Q34973576-C21F0161-7643-4F88-8A25-14507B01BD1C

P356

Q34973576-5088D2A8-6A66-4620-A1A3-7FA85240955E

P433

Q34973576-4E3B817F-81DD-45C1-88C6-C2BCB126323B

P478

Q34973576-05B40D54-EE91-4A2E-8206-18025CA11043

P50

Q34973576-0746BD43-848D-4BE8-9E21-328BA3A8B6A8

Q34973576-1366A477-FCDF-4752-98E6-C34291CBF59B

Q34973576-2271AC93-E04C-4B84-82C1-F0AE0CE69E2F

Q34973576-3586C99D-FF2C-47E9-9F11-3660D1403E47

Q34973576-979BF8C1-A0B2-4FF4-8B7A-FF0192CA1A88

Q34973576-CE08F014-845D-42A1-B35D-94C58802C486

Q34973576-DB6683A3-A969-4022-9A83-D6260B70A6FE

Q34973576-FA586AD2-1DBB-4DE4-81A0-AE2FC2AF0924

P577

Q34973576-90F93104-3E95-4200-8C80-7CDB81167501

P5875

Q34973576-438C4241-01A6-4AF1-B6D3-B7D92F8DC8B4

P6179

Q34973576-00FC22F3-1CF5-419E-B37E-DC6847F25B5D

P698

Q34973576-DCEEF642-4C78-435A-8919-AACF3C3E825F

P921

Q34973576-0CC182F9-FB8A-4C47-9621-4051EF23C731

Q34973576-59D2DADB-D447-4706-9963-F872181B88A0

Q34973576-A0C332C9-D106-44F3-B99D-6D04EA7E19FE

P356

P1433

P1476

Telomere length is an independ ...... n chronic lymphocytic leukemia

@en

P2093

A Rocci

http://www.w3.org/2001/XMLSchema#string

C Deambrogi

http://www.w3.org/2001/XMLSchema#string

C Lobetti Bodoni

http://www.w3.org/2001/XMLSchema#string

C Tarella

http://www.w3.org/2001/XMLSchema#string

D Rossi

http://www.w3.org/2001/XMLSchema#string

E Bernocco

http://www.w3.org/2001/XMLSchema#string

G Gaidano

http://www.w3.org/2001/XMLSchema#string

I Ricca

http://www.w3.org/2001/XMLSchema#string

L Bergui

http://www.w3.org/2001/XMLSchema#string

L Monitillo

http://www.w3.org/2001/XMLSchema#string

P2860

Telomerase, cell immortality, and cancer.

P2888

P304

1062-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2008.399

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Capello

Roberto Passera

Lorenzo De Paoli

Massimo Massaia

P577

2009-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24251655

http://www.w3.org/2001/XMLSchema#string

P6179

1033000615

http://www.w3.org/2001/XMLSchema#string

P698

19340005

http://www.w3.org/2001/XMLSchema#string

P921

telomere length